Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
S. Goto, D.L. Bhatt, J. Röther, M. Alberts, M.D. Hill, Y. Ikeda, et al.
Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis.
Am Heart J, 156 (2008), pp. 855-863
[2.]
V. Barrios, A. Calderón, C. Escobar, M. De la Figuera.
Pacientes con fibrilación auricular asistidos en consultas de atención primaria Estudio Val-FAAP.
Rev Esp Cardiol, 65 (2012), pp. 47-53
[3.]
J. Heeringa, D.A. Van der Kuip, A. Hofman, J.A. Kors, G. Van Herpen, B.H. Stricker, et al.
Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study.
Eur Heart J, 27 (2006), pp. 949-953
[4.]
R.G. Hart, L.A. Pearce, R.M. Rothbart, J.H. McAnulty, R.W. Asinger, J.L. Halperin, Stroke Prevention in Atrial Fibrillation Investigators.
Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy.
J Am Coll Cardiol, 35 (2000), pp. 183-187
[5.]
S.J. Connolly, M.D. Ezekowitz, S. Yusuf, J. Eikelboom, J. Oldgren, A. Parekh, et al.
Dabigatran versus warfarin in patients with atrial fibrillation.
N Engl J Med, 361 (2009), pp. 1139-1151
[6.]
M.R. Patel, K.W. Mahaffey, J. Garg, G. Pan, D.E. Singer, W. Hacke, et al.
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.
N Engl J Med, 365 (2011), pp. 883-891
[7.]
C.B. Granger, J.H. Alexander, J.J. McMurray, R.D. Lopes, E.M. Hylek, M. Hanna, et al.
Apixaban versus warfarin in patients with atrial fibrillation.
N Engl J Med, 365 (2011), pp. 981-992
Copyright © 2013. Elsevier España, S.L. y Sociedad Española de Medicina Rural y Generalista (SEMERGEN)
